While the abstract identifies β-catenin's involvement in myofibroblast activation and subsequent fibrosis, the specific molecular mechanisms linking β-catenin signaling to fibroblast-to-myofibroblast transition remain unexplained. This knowledge gap limits development of anti-fibrotic therapies. Gap type: unexplained_observation Source paper: Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review). (None, None, PMID:29786110)
Landscape Summary: How does β-catenin signaling mechanistically drive myofibroblast activation in organ fibrosis? is a 0.79 priority gap in fibrosis. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How does β-catenin signaling mechanistically drive myofibroblast activation in organ fibrosis? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: